Cargando…
Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era
The ability to stratify patients using a set of biomarkers, which predict that toxicity risk would allow for radiotherapy (RT) modulation and serve as a valuable tool for precision medicine and personalized RT. For patients presenting with tumors with a low risk of recurrence, modifying RT schedules...
Autores principales: | Azria, David, Lapierre, Ariane, Gourgou, Sophie, De Ruysscher, Dirk, Colinge, Jacques, Lambin, Philippe, Brengues, Muriel, Ward, Tim, Bentzen, Søren M., Thierens, Hubert, Rancati, Tiziana, Talbot, Christopher J., Vega, Ana, Kerns, Sarah L., Andreassen, Christian Nicolaj, Chang-Claude, Jenny, West, Catharine M. L., Gill, Corey M., Rosenstein, Barry S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406456/ https://www.ncbi.nlm.nih.gov/pubmed/28497027 http://dx.doi.org/10.3389/fonc.2017.00083 |
Ejemplares similares
-
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator
por: Azria, David, et al.
Publicado: (2018) -
STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics
por: Kerns, Sarah L., et al.
Publicado: (2013) -
Improving Patients’ Life Quality after Radiotherapy Treatment by Predicting Late Toxicities
por: Lapierre, Ariane, et al.
Publicado: (2022) -
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity
por: Lacombe, Jérôme, et al.
Publicado: (2019) -
One Size Fits All: Does the Dogma Stand in Radiation Oncology?
por: Azria, David, et al.
Publicado: (2016)